Chidamide Combined With Azacitidine and Mitoxantrone Liposome in the Treatment of Relapsed/Refractory (nTFHL)

NCT05772728 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

23

Enrollment

OTHER

Sponsor class

Conditions

T Cell Lymphoma

Interventions

DRUG: Cidapenem combined with azacitidine and mitoxantrone liposome (CAM) regimen

Sponsor

The First Affiliated Hospital with Nanjing Medical University